4-Fluoro-7-methoxy-2,3-dihydro-1H-inden-1-one, 95+%, 250mg

2-(Benzofuran-3-yl)ethanamine hydrochloride, 95.0%, 250mg

Antimony(III) oxide, min. 99%, pa, 100 g, plastic packaging.

N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-(dimethylamino)cyclohexyl]urea, 97%, 1g

4-BROMO-3-CHLOROPHENYLACETIC ACID, 95.0%, 25g

[(2,4-dichlorophenyl)methyl](2-methylpropyl)amine, 95.0%, 10g

1-phenyl-N-(1,3-thiazol-2-ylmethyl)methanamine hydrochloride, 95.0%, 1g

3-METHYL-1H-PYRAZOLO[3,4-B]PYRIDIN-5-AMINE, 95%, 5g

Bis(2-((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)phenyl)amine, 97%, 250mg

2,4-Dichloro-6-fluoroquinazoline, 99.0%, 25g

N-(6-aminohexyl)-2-nitrobenzenesulfonamide hydrochloride, 97%, 5g

3-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95+%, 100mg

[2-(1H-1,2,4-triazol-1-yl)ethyl]amine dihydrobromide, 95.0%, 250mg